Cbl Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine Vielzahl von Cbl-Antikörpern für die Untersuchung von Cbl-Proteinen in zellulären Signalwegen. Die Cbl-Antikörper sind für verschiedene Anwendungen validiert, darunter Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffineinbettungen (IHCP), Durchflusszytometrie (FCM) und Enzymimmunoassay (ELISA). Cbl-Proteine regulieren Rezeptor-Tyrosin-Kinasen und beeinflussen die zellulären Reaktionen auf Wachstumsfaktoren und Zytokine erheblich. Durch Ubiquitinierung und Endozytose halten Cbl-Proteine die zelluläre Homöostase und die Signaltreue aufrecht. Die Forschung, die sich auf Cbl-Proteine konzentriert, bringt weiterhin wichtige Erkenntnisse über die Krebsentwicklung und die Regulierung des Immunsystems zutage. Wissenschaftler auf der ganzen Welt verlassen sich auf monoklonale Cbl-Antikörper, um die zellbiologische Forschung voranzutreiben und neue therapeutische Ziele zu entdecken. Das Verständnis der Funktionen des Cbl-Proteins hilft bei der Identifizierung potenzieller Behandlungsmöglichkeiten für verschiedene Krankheiten und Störungen. Die Untersuchung von Cbl-vermittelten Signalwegen liefert wertvolle Erkenntnisse über Zellsignalmechanismen und deren Auswirkungen auf die menschliche Gesundheit. Die monoklonalen Antikörper von Santa Cruz Biotechnology für die Cbl-Forschung unterstützen Wissenschaftler dabei, sinnvolle Beiträge zur Zellbiologie und zur Entwicklung von Behandlungsmethoden für Krankheiten zu leisten.
Siehe auch...
ChemCruz™ Chemikalien Cbl Inhibitoren or Cbl Aktivatoren für die funktionelle Analyse zellulärer Antworten auf Cbl
Cbl Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
Cbl Antikörper (A-9) | sc-1651 | mouse IgG1 κ | 892-906 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 51 | ||
Cbl Antikörper (C-3) | sc-393543 | mouse IgG2a κ | 607-906 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 1 | ||
Cbl Antikörper (G-12) | sc-398282 | mouse IgG1 κ | 607-906 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
Cbl-3 Antikörper (F-2) | sc-390648 | mouse IgM κ | 442-474 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | neu | ||
Cbl-3 Antikörper (G-6) | sc-390649 | mouse IgG1 κ | 438-474 (h) | WB, IP, IF, ELISA | h | neu | ||
Cbl-b Antikörper (G-1) | sc-8006 | mouse IgG1 κ | 29-483 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 85 | ||
Cbl-b Antikörper (B-5) | sc-376409 | mouse IgG2b κ | 953-982 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 7 |
Phospho-Spezifische Cbl Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
p-Cbl Antikörper (E-10) | sc-377571 | mouse IgM κ | Tyr 700 (h) | WB, IP, IF, ELISA | m, r, h | 4 | ||
p-Cbl Antikörper (pY700.47) | sc-136013 | mouse IgG1 | Tyr 700 (h) | WB, IP, IF | m, r, h | neu |
Cbl CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Cbl CRISPR/Cas9 KO Plasmid (h) | sc-400561 | h | Gene Knockout | GFP | 0 | ||
Cbl HDR Plasmid (h) | sc-400561-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Cbl Double Nickase Plasmid (h) | sc-400561-NIC | h | Gene Knockout | Puromycin | 0 | ||
Cbl Double Nickase Plasmid (h2) | sc-400561-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Cbl CRISPR/Cas9 KO Plasmid (m) | sc-419490 | m | Gene Knockout | GFP | 0 | ||
Cbl HDR Plasmid (m) | sc-419490-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Cbl Double Nickase Plasmid (m) | sc-419490-NIC | m | Gene Knockout | Puromycin | 0 | ||
Cbl Double Nickase Plasmid (m2) | sc-419490-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Cbl-b CRISPR/Cas9 KO Plasmid (h) | sc-400828 | h | Gene Knockout | GFP | 0 | ||
Cbl-b HDR Plasmid (h) | sc-400828-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Cbl-b Double Nickase Plasmid (h) | sc-400828-NIC | h | Gene Knockout | Puromycin | 0 | ||
Cbl-b Double Nickase Plasmid (h2) | sc-400828-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Cbl-b CRISPR/Cas9 KO Plasmid (m) | sc-431578 | m | Gene Knockout | GFP | 0 | ||
Cbl-b HDR Plasmid (m) | sc-431578-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Cbl-b Double Nickase Plasmid (m) | sc-431578-NIC | m | Gene Knockout | Puromycin | 0 | ||
Cbl-b Double Nickase Plasmid (m2) | sc-431578-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Cbl-3 CRISPR/Cas9 KO Plasmid (h) | sc-407624 | h | Gene Knockout | GFP | 0 | ||
Cbl-3 HDR Plasmid (h) | sc-407624-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Cbl-3 Double Nickase Plasmid (h) | sc-407624-NIC | h | Gene Knockout | Puromycin | 0 | ||
Cbl-3 Double Nickase Plasmid (h2) | sc-407624-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Cbl-3 CRISPR/Cas9 KO Plasmid (m) | sc-429816 | m | Gene Knockout | GFP | 0 | ||
Cbl-3 HDR Plasmid (m) | sc-429816-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Cbl-3 Double Nickase Plasmid (m) | sc-429816-NIC | m | Gene Knockout | Puromycin | 0 | ||
Cbl-3 Double Nickase Plasmid (m2) | sc-429816-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Cbl CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Cbl CRISPR Activation Plasmid (h) | sc-400561-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl CRISPR Activation Plasmid (h2) | sc-400561-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl Lentiviral Activation Particles (h) | sc-400561-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl Lentiviral Activation Particles (h2) | sc-400561-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl CRISPR Activation Plasmid (m) | sc-419490-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl CRISPR Activation Plasmid (m2) | sc-419490-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl Lentiviral Activation Particles (m) | sc-419490-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl Lentiviral Activation Particles (m2) | sc-419490-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-b CRISPR Activation Plasmid (h) | sc-400828-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-b CRISPR Activation Plasmid (h2) | sc-400828-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-b Lentiviral Activation Particles (h) | sc-400828-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-b Lentiviral Activation Particles (h2) | sc-400828-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-b CRISPR Activation Plasmid (m) | sc-431578-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-b CRISPR Activation Plasmid (m2) | sc-431578-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-b Lentiviral Activation Particles (m) | sc-431578-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-b Lentiviral Activation Particles (m2) | sc-431578-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-3 CRISPR Activation Plasmid (h) | sc-407624-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-3 CRISPR Activation Plasmid (h2) | sc-407624-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-3 Lentiviral Activation Particles (h) | sc-407624-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-3 Lentiviral Activation Particles (h2) | sc-407624-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-3 CRISPR Activation Plasmid (m) | sc-429816-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-3 CRISPR Activation Plasmid (m2) | sc-429816-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-3 Lentiviral Activation Particles (m) | sc-429816-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cbl-3 Lentiviral Activation Particles (m2) | sc-429816-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
Cbl siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Cbl siRNA (h) | sc-29242 | h | Gene Silencing | N/A | 14 | ||
Cbl siRNA (h2) | sc-44254 | h | Gene Silencing | N/A | 1 | ||
Cbl shRNA Plasmid (h) | sc-29242-SH | h | Gene Silencing | Puromycin | 14 | ||
Cbl shRNA Plasmid (h2) | sc-44254-SH | h | Gene Silencing | Puromycin | 1 | ||
Cbl shRNA (h) Lentivirale Partikel | sc-29242-V | h | Gene Silencing | Puromycin | 14 | ||
Cbl shRNA (h2) Lentivirale Partikel | sc-44254-V | h | Gene Silencing | Puromycin | 1 | ||
Cbl siRNA (m) | sc-29949 | m | Gene Silencing | N/A | 3 | ||
Cbl shRNA Plasmid (m) | sc-29949-SH | m | Gene Silencing | Puromycin | 3 | ||
Cbl shRNA (m) Lentivirale Partikel | sc-29949-V | m | Gene Silencing | Puromycin | 3 | ||
Cbl-b siRNA (h) | sc-29950 | h | Gene Silencing | N/A | 9 | ||
Cbl-b shRNA Plasmid (h) | sc-29950-SH | h | Gene Silencing | Puromycin | 9 | ||
Cbl-b shRNA (h) Lentivirale Partikel | sc-29950-V | h | Gene Silencing | Puromycin | 9 | ||
Cbl-b siRNA (m) | sc-29951 | m | Gene Silencing | N/A | 0 | ||
Cbl-b shRNA Plasmid (m) | sc-29951-SH | m | Gene Silencing | Puromycin | 0 | ||
Cbl-b shRNA (m) Lentivirale Partikel | sc-29951-V | m | Gene Silencing | Puromycin | 0 | ||
Cbl-b siRNA (r) | sc-63343 | r | Gene Silencing | N/A | 0 | ||
Cbl-b shRNA Plasmid (r) | sc-63343-SH | r | Gene Silencing | Puromycin | 0 | ||
Cbl-b shRNA (r) Lentivirale Partikel | sc-63343-V | r | Gene Silencing | Puromycin | 0 | ||
Cbl-3 siRNA (h) | sc-40390 | h | Gene Silencing | N/A | 0 | ||
Cbl-3 shRNA Plasmid (h) | sc-40390-SH | h | Gene Silencing | Puromycin | 0 | ||
Cbl-3 shRNA (h) Lentivirale Partikel | sc-40390-V | h | Gene Silencing | Puromycin | 0 | ||
Cbl-3 siRNA (m) | sc-40391 | m | Gene Silencing | N/A | 0 | ||
Cbl-3 shRNA Plasmid (m) | sc-40391-SH | m | Gene Silencing | Puromycin | 0 | ||
Cbl-3 shRNA (m) Lentivirale Partikel | sc-40391-V | m | Gene Silencing | Puromycin | 0 |